Moreover, administration of exogenous TSLP is able to promote the apoptosis of human colon cancer cells, and inhibit colon tumor growth in a xenograft mouse model of colon cancer in a TSLPR-dependent manner. This evidence concerns the gene CRLF2 and colonic neoplasm.